Fig. 4From: Time-controlled adaptive ventilation (TCAV) accelerates simulated mucus clearance via increased expiratory flow rateScatterplot of EPF and proximal mucus movement for all trials within the TCAV groups (n = 30) with a line of best fit, for which R2 = 0.74Back to article page